Hana Pharm Co., Ltd. (293480.KS)
KRW 10850.0
(-0.73%)
KRW 10850.0
(-0.73%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 140.85 Billion KRW | 7.33% |
| 2022 | 131.23 Billion KRW | 0.32% |
| 2021 | 130.81 Billion KRW | 14.73% |
| 2020 | 114.02 Billion KRW | 3.47% |
| 2019 | 110.19 Billion KRW | 8.14% |
| 2018 | 101.9 Billion KRW | 7.98% |
| 2017 | 94.37 Billion KRW | 12.47% |
| 2016 | 83.91 Billion KRW | 19.2% |
| 2015 | 70.39 Billion KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 35.55 Billion KRW | -0.45% |
| 2024 Q2 | 34.6 Billion KRW | -2.68% |
| 2023 Q3 | 34.3 Billion KRW | -5.33% |
| 2023 Q4 | 35.71 Billion KRW | 4.12% |
| 2023 Q1 | 33.98 Billion KRW | -0.7% |
| 2023 Q2 | 36.23 Billion KRW | 6.61% |
| 2023 FY | 140.85 Billion KRW | 7.33% |
| 2022 FY | 131.23 Billion KRW | 0.32% |
| 2022 Q4 | 34.22 Billion KRW | 3.07% |
| 2022 Q3 | 33.2 Billion KRW | 4.49% |
| 2022 Q2 | 31.77 Billion KRW | -0.78% |
| 2022 Q1 | 32.02 Billion KRW | -9.67% |
| 2021 FY | 130.81 Billion KRW | 14.73% |
| 2021 Q2 | 32 Billion KRW | 6.87% |
| 2021 Q1 | 29.95 Billion KRW | -3.02% |
| 2021 Q4 | 35.45 Billion KRW | 6.17% |
| 2021 Q3 | 33.39 Billion KRW | 4.34% |
| 2020 Q3 | 28.95 Billion KRW | 6.92% |
| 2020 Q2 | 27.08 Billion KRW | -0.02% |
| 2020 FY | 114.02 Billion KRW | 3.47% |
| 2020 Q1 | 27.09 Billion KRW | -3.92% |
| 2020 Q4 | 30.88 Billion KRW | 6.64% |
| 2019 Q1 | 26.82 Billion KRW | 0.95% |
| 2019 FY | 110.19 Billion KRW | 8.14% |
| 2019 Q4 | 28.19 Billion KRW | 1.51% |
| 2019 Q3 | 27.77 Billion KRW | 1.42% |
| 2019 Q2 | 27.39 Billion KRW | 2.1% |
| 2018 Q3 | 25.2 Billion KRW | -2.33% |
| 2018 Q1 | 24.31 Billion KRW | 0.0% |
| 2018 FY | 101.9 Billion KRW | 7.98% |
| 2018 Q4 | 26.57 Billion KRW | 5.43% |
| 2018 Q2 | 25.8 Billion KRW | 6.15% |
| 2017 FY | 94.37 Billion KRW | 12.47% |
| 2017 Q3 | 24.96 Billion KRW | 0.0% |
| 2016 FY | 83.91 Billion KRW | 19.2% |
| 2015 FY | 70.39 Billion KRW | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 46.5 Billion KRW | -202.883% |
| Dong-A Socio Holdings Co., Ltd. | 364.1 Billion KRW | 61.315% |
| Ildong Holdings Co., Ltd. | 198.88 Billion KRW | 29.178% |
| HANDOK Inc. | 151.36 Billion KRW | 6.944% |
| Kukje Pharma Co., Ltd. | 67.22 Billion KRW | -109.53% |
| Yuhan Corporation | 564.5 Billion KRW | 75.048% |
| Dong-A ST Co., Ltd. | 322.21 Billion KRW | 56.285% |
| SAMSUNG PHARM. Co., LTD. | 23.74 Billion KRW | -493.15% |
| Hanmi Pharm. Co., Ltd. | 835.85 Billion KRW | 83.148% |
| Hanall Biopharma Co.,Ltd | 75.03 Billion KRW | -87.709% |
| Ilyang Pharmaceutical Co.,Ltd | 198.96 Billion KRW | 29.205% |
| Dong Sung Bio Pharm.Co.,Ltd. | 40.64 Billion KRW | -246.512% |
| MYUNGMOON Pharm co.,Ltd | 94.51 Billion KRW | -49.029% |
| Yuyu Pharma, Inc. | 46.5 Billion KRW | -202.883% |
| Ilsung Pharmaceuticals Co., Ltd. | 34.71 Billion KRW | -305.74% |
| REYON Pharmaceutical Co., Ltd. | 76.81 Billion KRW | -83.362% |
| Aprogen pharmaceuticals,Inc. | -12.04 Billion KRW | 1269.353% |
| JW Holdings Corporation | 446.15 Billion KRW | 68.429% |
| Ildong Pharmaceutical Co., Ltd. | 207.53 Billion KRW | 32.13% |
| Chong Kun Dang Pharmaceutical Corp. | 655.34 Billion KRW | 78.507% |
| JW Pharmaceutical Corporation | 335.67 Billion KRW | 58.038% |
| Shin Poong Pharm.Co.,Ltd. | 78.61 Billion KRW | -79.161% |
| Hyundai Pharmaceutical Co., Ltd. | 75.23 Billion KRW | -87.213% |
| Samil Pharmaceutical Co.,Ltd | 72.21 Billion KRW | -95.06% |
| Jeil Pharmaceutical Co.,Ltd | 183.81 Billion KRW | 23.371% |
| Yuyu Pharma, Inc. | 46.5 Billion KRW | -202.883% |
| Kwang Dong Pharmaceutical Co., Ltd. | 295.11 Billion KRW | 52.271% |
| Daewoong pharmaceutical Co.,Ltd | 681.55 Billion KRW | 79.333% |
| JW Pharmaceutical Corporation | 335.67 Billion KRW | 58.038% |
| Yuhan Corporation | 564.5 Billion KRW | 75.048% |
| Jeil Pharma Holdings Inc | 201.82 Billion KRW | 30.208% |
| Yungjin Pharm. Co., Ltd. | 70.93 Billion KRW | -98.559% |
| Suheung Co., Ltd. | 99.02 Billion KRW | -42.24% |
| JW Pharmaceutical Corporation | 335.67 Billion KRW | 58.038% |
| Samjin Pharmaceuticals Co., Ltd. | 145.89 Billion KRW | 3.452% |
| Korea United Pharm Inc. | 173.48 Billion KRW | 18.809% |
| CKD Bio Corp. | 5.01 Billion KRW | -2711.323% |
| Daewon Pharmaceutical Co., Ltd. | 254.23 Billion KRW | 44.596% |
| Dongwha Pharm.Co.,Ltd | 184.12 Billion KRW | 23.5% |
| Whan In Pharm Co.,Ltd. | 98.12 Billion KRW | -43.547% |
| Shin Poong Pharm.Co.,Ltd. | 78.61 Billion KRW | -79.161% |
| Chong Kun Dang Holdings Corp. | 371.49 Billion KRW | 62.084% |
| Boryung Corporation | 333.26 Billion KRW | 57.735% |
| Bukwang Pharmaceutical Co., Ltd. | 50.04 Billion KRW | -181.455% |
| Ilyang Pharmaceutical Co.,Ltd | 198.96 Billion KRW | 29.205% |
| JW Lifescience Corporation | 51.32 Billion KRW | -174.439% |